KRISTA LONG: Open Payments
NPI 1972030682 · VINITA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 21 payments from 11 companies in 2025. Trend: 2023 $389 · 2024 $348 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $112 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Lundbeck LLC | 1 | $26 |
| Exact Sciences Corporation | 1 | $23 |
| Seqirus USA Inc | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
Products named: OTEZLA, REXULTI, VERQUVO, XIFAXAN, TRELEGY ELLIPTA, Cologuard Collection Kit, Flucelvax, Repatha.
Industry payments across OK — which companies pay providers there.
